Humimic Biosystems has developed a comprehensive suite of five innovative organ-on-chip technologies protected by four strategic patents. Their portfolio includes the CoCo/NICE Chip for heart muscle contractility measurement with piezoelectric sensing, the AirLOC platform that uniquely combines nasal and lung airways, the versatile DynaMOC system that serves as the foundation for complex multilayered tissue modeling, the AV variant specifically optimized for heart valve research, and the MINT Chip for blood-brain barrier studies. This integrated ecosystem of human-relevant testing platforms addresses critical gaps in pharmaceutical drug development by providing earlier, more accurate data that could potentially save hundreds of millions in development costs by identifying ineffective compounds before expensive animal and human trials, ultimately bringing life-saving medications to market faster and more affordably.
Our Blood-Brain Barrier (BBB) chip recreates how the brain’s protective barrier works by combining different types of human brain and blood vessel cells in a tiny, realistic model. This allows us to study how the BBB responds to injury and disease and explore ways to protect or repair the brain.
Our Skeletal Muscle Chip recreates how human muscle tissue moves and responds to stress in a realistic lab model. This platform allows us to study muscle injury, repair, and strength loss—helping advance treatments for muscle diseases and improve recovery after trauma or repetitive strain.
Multi-layered, multi-chamber platform that simulates complex tissue environments with different flow profiles and mechanical strains, replicates the three-layered structure of aortic valves with appropriate fluid flows, designed specifically for heart valve disease research.
Our AirLoc chip recreates how the nasal airway breathes and responds to airflow, allowing us to study how airborne particles affect conditions like asthma and rhinitis and explore new ways to protect respiratory health.
Our Partners
